132 related articles for article (PubMed ID: 2144164)
1. Differential expression of the oncoproteins c-myc and c-myb in human lymphoproliferative disorders.
Siegert W; Beutler C; Langmach K; Keitel C; Schmidt CA
Eur J Cancer; 1990; 26(6):733-7. PubMed ID: 2144164
[TBL] [Abstract][Full Text] [Related]
2. c-myc and c-myb oncoproteins during induced maturation of myeloid and erythroid human leukemic cell lines.
Pedrazzoli P; Bains MA; Watson R; Fisher J; Hoy TG; Jacobs A
Cancer Res; 1989 Dec; 49(24 Pt 1):6911-6. PubMed ID: 2684403
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of c-erbB, c-myc and c-myb oncogene loci in human lymphomas and leukemias.
Roy-Burman P; Devi BG; Parker JW
Int J Cancer; 1983 Aug; 32(2):185-91. PubMed ID: 6603429
[TBL] [Abstract][Full Text] [Related]
4. Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias.
Golay J; Luppi M; Songia S; Palvarini C; Lombardi L; Aiello A; Delia D; Lam K; Crawford DH; Biondi A; Barbui T; Rambaldi A; Introna M
Blood; 1996 Mar; 87(5):1900-11. PubMed ID: 8634438
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of c-Myb protein in T-lymphocytic cell lines shows that it trans-activates the c-myc promoter.
Evans JL; Moore TL; Kuehl WM; Bender T; Ting JP
Mol Cell Biol; 1990 Nov; 10(11):5747-52. PubMed ID: 2233716
[TBL] [Abstract][Full Text] [Related]
6. Nuclear and cytoplasmic distribution of cellular myb protein in human haematopoietic cells evidenced by monoclonal antibody.
Bading H; Gerdes J; Schwarting R; Stein H; Moelling K
Oncogene; 1988 Sep; 3(3):257-65. PubMed ID: 3060791
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional and post-transcriptional regulation of c-myc, c-myb, and p53 during proliferation and differentiation of murine erythroleukemia cells treated with DFMO and DMSO.
Klinken SP; Holmes KL; Morse HC; Thorgeirsson SS
Exp Cell Res; 1988 Oct; 178(2):185-98. PubMed ID: 2458948
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of T cell proliferation in vivo: analysis of IL-2 receptor expression and activation of c-myc and c-myb oncogenes during lymphatic regeneration.
Sihvola M; Sistonen L; Alitalo K; Hurme M
Biochem Biophys Res Commun; 1989 Apr; 160(1):181-8. PubMed ID: 2496686
[TBL] [Abstract][Full Text] [Related]
9. Expression of cellular oncogenes in primary cells from human acute leukemias.
Mavilio F; Sposi NM; Petrini M; Bottero L; Marinucci M; De Rossi G; Amadori S; Mandelli F; Peschle C
Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4394-8. PubMed ID: 3520570
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogenic T3 and T11 activation signals.
Shipp MA; Reinherz EL
J Immunol; 1987 Oct; 139(7):2143-8. PubMed ID: 2821108
[TBL] [Abstract][Full Text] [Related]
11. Specific expression of cellular oncogenes c-myc and c-myb in T-cell lines established from three types of bovine lymphosarcomas.
Ishiguro N; Matsui T; Shinagawa M
Am J Vet Res; 1993 Dec; 54(12):2010-4. PubMed ID: 8116930
[TBL] [Abstract][Full Text] [Related]
12. c-myb gene analysis in T-cell malignancies with del(6q).
Okada M; Tada M; Kanda N; Masuda M; Mizoguchi H; Kazuma M; Wada E; Kubota K; Nomura Y
Cancer Genet Cytogenet; 1990 Sep; 48(2):229-36. PubMed ID: 2204478
[TBL] [Abstract][Full Text] [Related]
13. p75c-myb expression in leukemia-lymphoma cells correlated with proliferation and differentiation.
Ohnishi H; Kamano H; Tanaka T; Okabe A; Irino S
Leuk Res; 1990; 14(5):423-32. PubMed ID: 2189045
[TBL] [Abstract][Full Text] [Related]
14. Nuclear oncoprotein expression as a function of lineage, differentiation stage, and proliferative status of normal human hematopoietic cells.
Kastan MB; Stone KD; Civin CI
Blood; 1989 Oct; 74(5):1517-24. PubMed ID: 2506946
[TBL] [Abstract][Full Text] [Related]
15. Myb binding sites mediate negative regulation of c-myb expression in T-cell lines.
Guerra J; Withers DA; Boxer LM
Blood; 1995 Sep; 86(5):1873-80. PubMed ID: 7655015
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of the c-myb proto-oncogene marks the pre-B cell/B cell junction in murine B lymphoid tumors.
Bender TP; Kuehl WM
J Immunol; 1987 Dec; 139(11):3822-7. PubMed ID: 3316389
[TBL] [Abstract][Full Text] [Related]
17. c-myc and c-myb expression in acute myelogenous leukemia.
Gopal V; Hulette B; Li YQ; Kuvelkar R; Raza A; Larson R; Goldberg J; Tricot G; Bennett J; Preisler H
Leuk Res; 1992 Oct; 16(10):1003-11. PubMed ID: 1405703
[TBL] [Abstract][Full Text] [Related]
18. Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer.
Bepler G; Bading H; Heimann B; Kiefer P; Havemann K; Moelling K
Oncogene; 1989 Jan; 4(1):45-50. PubMed ID: 2536917
[TBL] [Abstract][Full Text] [Related]
19. Constitutive versus cell cycle regulation of c-myb mRNA expression correlates with developmental stages in murine B lymphoid tumors.
Catron KM; Purkerson JM; Isakson PC; Bender TP
J Immunol; 1992 Feb; 148(3):934-42. PubMed ID: 1730880
[TBL] [Abstract][Full Text] [Related]
20. Identification and preferential expression in thymic and bursal lymphocytes of a c-ets oncogene-encoded Mr 54,000 cytoplasmic protein.
Ghysdael J; Gegonne A; Pognonec P; Dernis D; Leprince D; Stehelin D
Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1714-8. PubMed ID: 3006066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]